McDermott Will & Emery is pleased to announce that James S. Cohen will join the Firm’s Health Industry Advisory and Life Sciences & Medical Devices Practice Groups as a partner and leader of the firm’s FDA practice in the Washington, D.C. office on July 27th. Mr. Cohen focuses his practice on the development, clinical investigation, [...]
DCS, a Recovery Audit Contractor (RAC) for the Centers for Medicare & Medicaid Services (CMS), has signed a five-year license agreement with Milliman Care Guidelines (see also Medicare and Medicaid).DCS, A Performant Company, will use the Milliman Care Guidelines content and software to review Medicare claims in 12 Northeastern and Mid-Atlantic states and districts [...]
Baxter International Inc. announced that the U.S. Food and Drug Administration (FDA) has issued its final order regarding the previously communicated recall of COLLEAGUE infusion pumps from the U.S. market. Baxter will offer replacement infusion pumps or refunds to owners of COLLEAGUE pumps and will execute the recall over the next two years to minimize [...]
Pharmaceutical company Bionovo Inc (Nasdaq:BNVI) announced today the receipt of final guidance from the European Medicines Agency (EMA) in order to advance Menerba, the company’s lead drug candidate for menopausal symptoms, to Phase 3 clinical trials in Europe.This guidance reportedly defines the clinical and regulatory pathway to a European marketing authorisation for Menerba.The company plans [...]
ST. LOUIS(BUSINESS WIRE) EGHC, the parent company of Essence Healthcare and other subsidiaries, today announced that Denis A. Cortese, MD, a champion of high quality and patient-centered health care, will join the company’s Board of [...]
FLORHAM PARK, N.J., July 29 /PRNewswire/ Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA? (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA? was designated [...]
July 29, 2010Contact: Kate Cyrul / Bergen Kenny (Harkin) 202-224-3254Brian Weiss (Bayh) 202-224-6807Shana Marchio (Bond) 202-224-0309Harkin, Bayh, Bond Introduce Bipartisan Bill to Improve Health and Lower Health Care Costs through Medical-Legal PartnershipsWASHINGTON, D.C. -Senators Tom Harkin (D-IA), Evan Bayh (D-IN) and Kit Bond (R-MO) today introduced the bipartisan Medical-Legal Partnerships for Health Act, legislation aimed [...]
WASHINGTON, July 29 The office of Sen. Evan Bayh, D-Ind., issued the following news release:Senators Evan Bayh (D-IN), Tom Harkin (D-IA) and Kit Bond (R-MO) today introduced the bipartisan Medical-Legal Partnerships for Health Act, legislation aimed at improving public health and lowering health care costs through medical-legal partnerships (MLP). MLPs bring legal aid attorneys [...]
Health care company Abbott (NYSE:ABT) stated on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR (niacin extended-release / simvastatin), a cholesterol medication.The company claimed the new SIMCOR dosage strengths combine 40 mg of simvastatin, which is the most commonly prescribed dose of simvastatin, [...]
Dublin – Research and Markets has announced the addition of Frost & Sullivan’s new report "Global Pharma-Biotech Alliance Analysis" to their offering.This Frost & Sullivan research service titled Global Pharma-Biotech Alliance Analysis provides a detailed analysis of the trends, opportunities, and unmet needs in the decision to enter emerging markets by pharmaceutical companies. In this [...]
